ALDH1A3 and neuroblastoma: In addition, high ALDH1A3 expression is associated with worse patient survival in prostate, glioblastoma, neuroblastoma, pancreatic, gastric, gall bladder, colon, and intrahepatic cholangiocarcinoma cancers [41,45,46,47,48,49,50,51,52].